Assessment of complement interference in anti-Müllerian hormone immunoassays

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Reflex TSH strategy: the good, the bad and the ugly
4. Review
5. Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review
6. Mini Review
7. Clinical application of presepsin as diagnostic biomarker of infection: overview and updates
8. Opinion Paper
9. Gut microbiotas and immune checkpoint inhibitor therapy response: a causal or coincidental relationship?
10. EFLM Paper
11. Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters
12. General Clinical Chemistry and Laboratory Medicine
13. Pre-, post- or no acidification of urine samples for calcium analysis: does it matter?
14. Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis
15. Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study
16. Multi-site performance evaluation and Sigma metrics of 20 assays on the Atellica chemistry and immunoassay analyzers
17. Plasma creatinine medians from patients partitioned by gender and age used as a tool for assessment of analytical stability at different concentrations
18. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays
19. Method comparison of four clinically available assays for serum free light chain analysis
20. Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone
21. Repeatability and reproducibility of lipoprotein particle profile measurements in plasma samples by ultracentrifugation
22. Reference Values and Biological Variations
23. A study on reference interval transference via linear regression
24. Cancer Diagnostics
25. Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer
26. Cardiovascular Diseases
27. Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination
28. Acknowledgment
29. Letters to the Editor
30. Are icteric and lipemic indices reliable to screen for hyperbilirubinemia and hypertriglyceridemia?
31. Anti-streptavidin antibodies as a cause of false-positive results of streptavidin-based autoantibody assays
32. Assessment of complement interference in anti-Müllerian hormone immunoassays
33. Validating thyroid-stimulating hormone (TSH) reflexive testing cutpoints in a tertiary care institution
34. Results of the second external quality assessment for human papillomavirus genotyping in Shanghai, China
35. Development of suitable external quality control material for G6PD deficiency screening with the fluorescent spot test
36. Non-linearity in commercially available lipase assays: still gaps to close
37. JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential
38. Congress Abstracts
39. 11^th National Scientifc Congress SPML